City
Epaper

Autopsy study shows Covid harms brain like Alzheimer's, Parkinson's

By IANS | Published: June 23, 2021 4:15 PM

New York, June 23 People who died of Covid-19 showed signs that were similar to the brains of ...

Open in App

New York, June 23 People who died of Covid-19 showed signs that were similar to the brains of individuals who died of neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, according to a study.

Both groups presented similar inflammation and impairment in brain circuits, said researchers from the Stanford School of Medicine and the Saarland University in Germany.

The findings, published in the journal Nature, may help explain why about one-third of individuals hospitalised for Covid report symptoms of neurological problems like fuzzy thinking, forgetfulness, difficulty concentrating, and depression.

The team analysed brain tissues from eight individuals who died of the disease, and brain samples from 14 people who died of other causes were used as controls for the study.

"The brains of patients who died from severe Covid-19 showed profound molecular markers of inflammation, even though those patients didn't have any reported clinical signs of neurological impairment," said Tony Wyss-Coray, Professor of Neurology and Neurological Sciences at Stanford.

"Viral infection appears to trigger inflammatory responses throughout the body that may cause inflammatory signalling across the blood-brain barrier, which in turn could trip off neuroinflammation in the brain," he added.

Further, the team found that the activation levels of many genes, associated with inflammatory processes, differed in the Covid-19 patients' brains versus the control group's brains.

There also were signs of distress in neurons in the cerebral cortex, the brain region that plays a key role in decision-making, memory and mathematical reasoning.

The outermost layers of the cerebral cortex of patients who died of Covid-19 showed molecular changes suggesting suppressed signalling by excitatory neurons, along with heightened signalling by inhibitory neurons, which act like brakes on excitatory neurons. This kind of signalling imbalance has been associated with cognitive deficits and neurodegenerative conditions such as Alzheimer's disease, the researchers explained.

In addition, the peripheral immune cells called T cells, were significantly more abundant in brain tissue from dead Covid-19 patients. In healthy brains, these immune cells are few and far between.

"It's likely that many Covid-19 patients, especially those reporting or exhibiting neurological problems or those who are hospitalised, have these neuroinflammatory markers we saw in the people we looked at who had died from the disease," Wyss-Coray said. It may be possible to find out by analysing these patients' cerebrospinal fluid, whose contents to some extent mirror those of the living brain.

"Our findings may help explain the brain fog, fatigue, and other neurological and psychiatric symptoms of long Covid," he noted.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Saarland UniversityGermanyStanfordStanford School Of MedicineUds
Open in App

Related Stories

EntertainmentSaiyami Kher to Compete in Ironman Race in Germany's Brandenburg Forest

InternationalLightning Strike in Germany Injures 10 People, Four Lives in Danger

BusinessIndia Poised to Become World’s Third Largest Consumer Market by 2026 Outpacing Germany, Japan

InternationalSouth Korea, German Official Discuss Possibility of Unified Korea

International“Blatant Interference”: India Lodges Strong Protest With Germany Over Statement on Arvind Kejriwal Arrest

Health Realted Stories

HealthSouth Sudan receives first batch of malaria vaccines

HealthUK declares itself free from bird flu

HealthNIMHANS conferred with Nelson Mandela Award 2024 for health promotion

HealthICC Cricket World Cup 2023 had 41 per cent surrogate ads on smokeless tobacco: ICMR

HealthCan exercise raise risk of knee osteoarthritis?